A potential strategy for high-grade gliomas: Combination treatment with lithium chloride and BmK CT

Biotechnology Letters

Volumn 34, Issue 1, 2012, Pages 9-17

  Fu, Yuejun ^a   Zheng, Shuhua ^a   Huang, Rui ^a   An, Na ^a   Zheng, Yali ^a   Zhang, Zhiyun ^a   Liang, Aihua ^a  

^a SHANXI UNIVERSITY   (China)

Author keywords

Catenin; Buthus martensii Karsch CT; Glioma; Lithium chloride; Matrix metalloproteinase 2

Indexed keywords

BUTHUS MARTENSII; COMBINATION THERAPY; COMBINATION TREATMENTS; GLIOMA; GLIOMA CELLS; HIGH-GRADE GLIOMAS; IMMUNOFLUORESCENCE STAINING; INVASIVENESS; LEADING EDGE; LITHIUM CHLORIDE; LOCALIZATION PATTERNS; MATRIX METALLOPROTEINASE-2;

CATALYST ACTIVITY; CHEMOTHERAPY; CHLORINE COMPOUNDS; LITHIUM;

TUMORS;

ANTINEOPLASTIC AGENT; BETA CATENIN; BMK CTA PROTEIN, BUTHUS MARTENSII; GELATINASE A; LITHIUM CHLORIDE; MMP2 PROTEIN, HUMAN; SCORPION VENOM;

ARTICLE; DRUG ANTAGONISM; DRUG POTENTIATION; GLIOMA; HUMAN; METABOLISM; ORGAN CULTURE TECHNIQUE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; BETA CATENIN; CELL LINE, TUMOR; DRUG SYNERGISM; GLIOMA; HUMANS; LITHIUM CHLORIDE; MATRIX METALLOPROTEINASE 2; ORGAN CULTURE TECHNIQUES; SCORPION VENOMS;

EID: 83055191202     PISSN: 01415492     EISSN: 15736776     Source Type: Journal    
DOI: 10.1007/s10529-011-0741-2     Document Type: Article

References (26)

1. Asano K, Duntsch CD, Zhou Q, Weimar JD, Bordelon D, Robertson JH, Pourmotabbed T (2004) Correlation of N-cadherin expression in high grade gliomas with tissue invasion. J Neurooncol 70: 3-15.
2. Del Duca D, Werbowetski T, Del Maestro RF (2004) Spheroid preparation from hanging drops: characterization of a model of brain tumor invasion. J Neurooncol 67: 295-303.
3. Deshane J, Garner CC, Sontheimer H (2003) Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2. J Biol Chem 278: 4135-4144.
4. Etienne-Manneville S, Hall A (2003) Cdc42 regulates GSK-3beta and adenomatous polyposis coli to control cell polarity. Nature 421: 753-756.
5. Fu YJ, Yin LT, Liang AH, Zhang CF, Wang W, Chai BF, Yang JY, Fan XJ (2007) Therapeutic potential of chlorotoxin-like neurotoxin from the Chinese scorpion for human gliomas. Neurosci Lett 412: 62-67.
6. Fu YJ, An N, Chan KG, Wu YB, Zheng SH, Liang AH (2011) A model of BmK CT in inhibiting glioma cell migration via matrix metalloproteinase-2 from experimental and molecular dynamics simulation study. Biotechnol Lett 33(7): 1309-1317.
7. Giese A, Bjerkvig R, Berens ME, Westphal M (2003) Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 21: 1624-1636.
8. Henderson N, Markwick LJ, Elshaw SR, Freyer AM, Knox AJ, Johnson SR (2007) Collagen I and thrombin activate MMP-2 by MMP-14-dependent and -independent pathways: implications for airway smooth muscle migration. Am J Physiol Lung Cell Mol Physiol 292: L1030-L1038.
9. Jones KJ, Korb E, Kundel MA, Kochanek AR, Kabraji S, McEvoy M, Shin CY, Wells DG (2008) CPEB1 regulates beta-catenin mRNA translation and cell migration in astrocytes. Glia 56: 1401-1413.
10. Kato M, Lledo PM, Vincent JD (1991) Blockade by lithium ions of potassium channels in rat anterior pituitary cells. Am J Physiol 261: C218-C223.
11. Kotliarova S, Pastorino S, Kovell LC, Kotliarov Y, Song H, Zhang W, Bailey R, Maric D, Zenklusen JC, Lee J, Fine HA (2008) Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation. Cancer Res 68: 6643-6651.
12. Kuroda T, Rabkin SD, Martuza RL (2006) Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector. Cancer Res 66: 10127-10135.
13. Laquintana V, Trapani A, Denora N, Wang F, Gallo JM, Trapani G (2009) New strategies to deliver anticancer drugs to brain tumors. Expert Opin Drug Deliv 6: 1017-1032.
14. Liang CC, Park AY, Guan JL (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2: 329-333.
15. Lin HC, Song TY, Hu ML (2009) S-Adenosylhomocysteine promotes the invasion of C6 glioma cells via increased secretion of matrix metalloproteinase-2 in murine microglial BV2 cells. Toxicol Sci 112: 322-330.
16. Lubner SJ, Kunnimalaiyaan M, Holen KD, Ning L, Ndiaye M, Loconte NK, Mulkerin DL, Schelman WR, Chen H (2011) A preclinical and clinical study of lithium in low-grade neuroendocrine tumors. Oncologist 16: 452-457.
17. Maher MT, Flozak AS, Stocker AM, Chenn A, Gottardi CJ (2009) Activity of the beta-catenin phosphodestruction complex at cell-cell contacts is enhanced by cadherin-based adhesion. J Cell Biol 186: 219-228.
18. Markovic DS, Glass R, Synowitz M, Rooijen N, Kettenmann H (2005) Microglia stimulate the invasiveness of glioma cells by increasing the activity of metalloprotease-2. J Neuropathol Exp Neurol 64: 754-762.
19. McFerrin MB, Sontheimer H (2006) A role for ion channels in glioma cell invasion. Neuron Glia Biol 2: 39-49.
20. Nowicki MO, Dmitrieva N, Stein AM, Cutter JL, Godlewski J, Saeki Y, Nita M, Berens ME, Sander LM, Newton HB, Chiocca EA, Lawler S (2008) Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3. Neuro Oncol 10: 690-699.
21. Song L, Zhou T, Jope RS (2004) Lithium facilitates apoptotic signaling induced by activation of the Fas death domain-containing receptor. BMC Neurosci 5: 20.
22. Takahashi S, Yamada-Okabe H, Hamada K, Ohta S, Kawase T, Yoshida K, Toda M (2011) Downregulation of uPARAP mediates cytoskeletal rearrangements and decreases invasion and migration properties in glioma cells. J Neurooncol 103: 267-276.
23. Tsai LK, Leng Y, Wang Z, Leeds P, Chuang DM (2010) The mood stabilizers valproic acid and lithium enhance mesenchymal stem cell migration via distinct mechanisms. Neuropsychopharmacology 35: 2225-2237.
24. Weaver AK, Bomben VC, Sontheimer H (2006) Expression and function of calcium-activated potassium channels in human glioma cells. Glia 54: 223-233.
25. Zhang WV, Jüllig M, Connolly AR, Stott NS (2005) Early gene response in lithium chloride induced apoptosis. Apoptosis 10: 75-90.
26. Zhao J, Qiao W, Zhang Y, Shao X (2010) Preparation and in vitro evaluation of 131I-BmK CT as a glioma-targeted agent. Cancer Biother Radiopharm 25: 353-359.